1) Gordon T, Tyreman N, Raji MA. The basis for diminished functional recovery after delayed peripheral nerve repair. J Neurosci 2011;31(14):5325-34.
2) Nagano A, Tsuyama N, Ochiai N, et al. Direct nerve crossing with the intercostal nerve to treat avulsion injuries of the brachial plexus. J Hand Surg Am 1989;14(6):980-5.
3) Coulet B, Boretto JG, Lazerges C, et al. A comparison of intercostal and partial ulnar nerve transfers in restoring elbow flexion following upper brachial plexus injury (C5-C6+/-C7). J Hand Surg Am 2010;35(8):1297-303.
4) Chao T, Frump D, Lin M, et al. Matrix metalloproteinase 3 deletion preserves denervated motor endplates after traumatic nerve injury. Ann Neurol 2013;73(2):210-23.
5) Kurimoto S, Jung J, Tapadia M, et al. Activation of the Wnt/β-catenin signaling cascade after traumatic nerve injury. Neuroscience 2015;294:101-8.
6) Jang YC, Van Remmen H. Age-associated alterations of the neuromuscular junction. Exp Gerontol 2011;46(2-3):193-8.
7) Krakora D, Macrander C, Suzuki M. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurol Res Int 2012;2012:379657. doi:10.1155/2012/379657.
8) Miyoshi S, Tezuka T, Arimura S, et al. DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol Med 2017;9(7):880-9.
9) Ueta R, Sugita S, Minegishi Y, et al. DOK7 gene therapy enhances neuromuscular junction innervation and motor function in aged mice. iScience 2020;23(8):101385. doi:10.1016/j.isci.2020.101385.
10) Hettwer S, Lin S, Kucsera S, et al. Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction. PLoS One 2014;9(2):e88739. doi:10.1371/journal.pone.0088739.